Update on the Treatment of Pulmonary Arterial Hypertension

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
ARQUIVOS BRASILEIROS CARDIOLOGIA
Citação
ARQUIVOS BRASILEIROS DE CARDIOLOGIA, v.117, n.4, p.750-763, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
In the last decades, important advances have been made in the treatment of pulmonary arterial hypertension (PAH), a severe, progressive, incurable, and potentially fatal disease. For an adequate therapy, correct hemodynamic diagnosis and etiology classification are fundamental. Many etiologies - rheumatic disease, portal hypertension, congenital heart diseases, schistosomiasis - require specific measures, in addition to drug therapy for PAH. The specific therapy for PAH is based on medications that act on three pathophysiological pathways - prostacyclin, endothelin, and nitric oxide pathways. These drugs have multiple presentations (oral, intravenous, subcutaneous, and inhaled) and have changed the history of PAH. This review presents an overview of drug therapy strategies and different forms and peculiarities of PAH.
Muitos avanços ocorreram nas últimas décadas na terapêutica da hipertensão arterial pulmonar (HAP), uma doença grave, progressiva, incurável e potencialmente fatal. Para seu tratamento adequado, são fundamentais o diagnóstico hemodinâmico e a classificação de sua etiologia, em que várias delas (colagenoses, hipertensão portal, cardiopatia congênitas, esquistossomose) requerem medidas específicas, além do tratamento farmacológico característico para HAP. O tratamento com fármacos-alvo para HAP baseia-se em produtos farmacêuticos que interferem em três vias fisiopatológicas moleculares: da prostaciclina, da endotelina e do óxido nítrico. Tais fármacos apresentam múltiplas apresentações (oral, endovenosa, subcutânea e inalatória) e mudaram a história da HAP. Essas medicações e suas estratégias de uso, assim como particularidades das diferentes formas de HAP, são o foco desta revisão.
Palavras-chave
Pulmonary Arterial Hypertension, Pulmonary Hypertension, Diagnosis, Therapeutics, Hipertensão arterial pulmonar, Hipertensão Pulmonar, Diagnóstico, Terapêutica
Referências
  1. Aguilar RV, 2000, AM J RESP CRIT CARE, V162, P1846, DOI 10.1164/ajrccm.162.5.2004042
  2. Aithala R, 2017, INT J RHEUM DIS, V20, P5, DOI 10.1111/1756-185X.13001
  3. Alves-Jr JL, 2018, J HEART LUNG TRANSPL, V37, P692, DOI 10.1016/j.healun.2018.02.005
  4. Alves JL, 2017, SEMIN RESP CRIT CARE, V38, P561, DOI 10.1055/s-0037-1606577
  5. Alves JL, 2015, CHEST, V147, P495, DOI 10.1378/chest.14-1036
  6. Avouac J, 2010, J RHEUMATOL, V37, P2290, DOI 10.3899/jrheum.100245
  7. Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140
  8. Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504
  9. Beghetti M, 2009, J AM COLL CARDIOL, V53, P733, DOI 10.1016/j.jacc.2008.11.025
  10. Benza RL, 2019, CHEST, V156, P323, DOI 10.1016/j.chest.2019.02.004
  11. Boucly A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00889-2017
  12. Thorne S, 2006, J FAM PLAN REPROD H, V32, P75, DOI 10.1783/147118906776276486
  13. CHRISTMAN BW, 1992, NEW ENGL J MED, V327, P70, DOI 10.1056/NEJM199207093270202
  14. Tongers J, 2007, AM HEART J, V153, P127, DOI 10.1016/j.ahj.2006.09.008
  15. Tuder RM, 1999, AM J RESP CRIT CARE, V159, P1925, DOI 10.1164/ajrccm.159.6.9804054
  16. Broberg CS, 2007, J AM COLL CARDIOL, V50, P634, DOI 10.1016/j.jacc.2007.04.056
  17. Calderaro D, 2019, ARQ BRAS CARDIOL, V113, P419, DOI 10.5935/abc.20190188
  18. Dos CJC, 2011, EXPERT REV RESP MED, V5, P675, DOI [10.1586/ers.11.58, 10.1586/ERS.11.58]
  19. Fernandes CJC, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00307-2018
  20. Chester Adrian H, 2017, Glob Cardiol Sci Pract, V2017, P14, DOI 10.21542/gcsp.2017.14
  21. Chester Adrian H, 2014, Glob Cardiol Sci Pract, V2014, P62, DOI 10.5339/gcsp.2014.29
  22. Desai CS, 2011, CURR OPIN RHEUMATOL, V23, P545, DOI 10.1097/BOR.0b013e32834b8975
  23. Chin KM, 2020, AM J RESP CRIT CARE, V201
  24. Chinello P, 2016, EXPERT REV CLIN PHAR, V9, P715, DOI 10.1586/17512433.2016.1151785
  25. Coghlan JG, 2018, AM J CARDIOVASC DRUG, V18, P37, DOI 10.1007/s40256-017-0262-z
  26. Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301
  27. Cosarderelioglu C, 2016, EXP CLIN TRANSPLANT, V14, P113, DOI 10.6002/ect.2015.0351
  28. DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343
  29. Degano B, 2009, EUR RESPIR J, V33, P92, DOI 10.1183/09031936.00094808
  30. Degano B, 2010, AIDS, V24, P67, DOI 10.1097/QAD.0b013e328331c65e
  31. DeJesus E, 2019, PULM CIRC, V9, DOI 10.1177/2045894019848644
  32. Denton CP, 2018, NAT REV RHEUMATOL, V14, P511, DOI 10.1038/s41584-018-0062-0
  33. Frost A, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01904-2018
  34. Fernandes CJCD, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01527-2017
  35. Drakopoulou M, 2018, HEART, V104, P1963, DOI 10.1136/heartjnl-2017-312881
  36. Duarte AG, 2013, CHEST, V143, P1330, DOI 10.1378/chest.12-0528
  37. Elliott CG, 2010, CHEST, V137, p85S, DOI 10.1378/chest.09-2816
  38. Engelfriet PM, 2007, HEART, V93, P682, DOI 10.1136/hrt.2006.098848
  39. Fernandes CJ, 2019, CHEST, V156, P200, DOI 10.1016/j.chest.2019.04.099
  40. Fernandes CJCS, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0130-3
  41. Fernandes CJCS, 2012, CHEST, V141, P923, DOI 10.1378/chest.11-0483
  42. Galie Nazzareno, 2003, Am J Respir Med, V2, P123
  43. Fernandes CJC, 2019, CURR OPIN PULM MED, V25, P391, DOI 10.1097/MCP.0000000000000603
  44. Fernandes CJCS, 2020, J Bras Pneumol, V46
  45. FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580
  46. Galie N, 2015, NEW ENGL J MED, V373, P834, DOI 10.1056/NEJMoa1413687
  47. Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010
  48. Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510
  49. Galie N, 2006, CIRCULATION, V114, P48, DOI 10.1161/CIRCULATIONAHA.106.630715
  50. Galie N, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01889-2018
  51. Galie N, 2017, J AM COLL CARDIOL, V69, P2808, DOI 10.1016/j.jacc.2017.03.597
  52. Galie N, 2015, EUR RESPIR J, V46, P903, DOI 10.1183/13993003.01032-2015
  53. Hoeper MM, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00740-2017
  54. Gavilanes F, 2016, CURR OPIN PULM MED, V22, P408, DOI 10.1097/MCP.0000000000000300
  55. Gavilanes F, 2014, J BRAS PNEUMOL, V40, P609, DOI 10.1590/S1806-37132014000600004
  56. Ghofrani HA, 2013, NEW ENGL J MED, V369, P330, DOI 10.1056/NEJMoa1209655
  57. Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657
  58. Guillevin L, 2013, EUR RESPIR REV, V22, P535, DOI 10.1183/09059180.00005713
  59. Hachinski V, 2012, ARCH NEUROL-CHICAGO, V69, P169, DOI 10.1001/archneurol.2011.1698
  60. Hao YJ, 2014, EUR RESPIR J, V44, P963, DOI 10.1183/09031936.00182813
  61. Hao YJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0517-5
  62. Kajita LJ, 2001, CATHETER CARDIO INTE, V52, P49, DOI 10.1002/1522-726X(200101)52:1<49::AID-CCD1012>3.0.CO;2-0
  63. Hemnes AR, 2015, PULM CIRC, V5, P435, DOI 10.1086/682230
  64. Hoeper MM, 2007, EUR RESPIR J, V30, P1096, DOI 10.1183/09031936.00032407
  65. Hoeper MM, 2016, LANCET RESP MED, V4, P306, DOI 10.1016/S2213-2600(15)00543-3
  66. Hoette S, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0115-y
  67. Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291
  68. Humbert M, 2010, EUR RESPIR REV, V19, P59, DOI 10.1183/09059180.00007309
  69. Jais X, 2008, ARTHRITIS RHEUM-US, V58, P521, DOI 10.1002/art.23303
  70. Jais X, 2012, EUR RESPIR J, V40, P881, DOI 10.1183/09031936.00141211
  71. Jardim C, 2014, CURR OPIN PULM MED, V20, P409, DOI 10.1097/MCP.0000000000000086
  72. Jarrett H, 2017, CURR OPIN HIV AIDS, V12, P566, DOI 10.1097/COH.0000000000000418
  73. Luppino Assad Ana Paula, 2018, Clin Exp Rheumatol, V36 Suppl 113, P186
  74. Kaufmann P, 2015, BRIT J CLIN PHARMACO, V80, P670, DOI 10.1111/bcp.12650
  75. Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0
  76. Kiely DG, 2019, EUR HEART J SUPPL, V21, P9, DOI 10.1093/eurheartj/suz204
  77. Kim JS, 2018, LUPUS, V27, P1769, DOI 10.1177/0961203318788163
  78. Krowka MJ, 2006, HEPATOLOGY, V44, P1502, DOI 10.1002/hep.21431
  79. Kylhammar D, 2018, EUR HEART J, V39, P4175, DOI 10.1093/eurheartj/ehx257
  80. Lajoie AC, 2016, LANCET RESP MED, V4, P291, DOI 10.1016/S2213-2600(16)00027-8
  81. Langleben D, 2015, ANN INTERN MED, V162, P154, DOI 10.7326/M14-1402
  82. Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204
  83. Launay D, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0056-2017
  84. Le Pavec J, 2008, AM J RESP CRIT CARE, V178, P637, DOI 10.1164/rccm.200804-613OC
  85. Madden BP, 2009, INT J OBSTET ANESTH, V18, P156, DOI 10.1016/j.ijoa.2008.10.006
  86. Maron BA, 2020, LANCET RESP MED, V8, P873, DOI 10.1016/S2213-2600(20)30317-9
  87. Maron BA, 2016, CIRCULATION, V133, P1240, DOI 10.1161/CIRCULATIONAHA.115.020207
  88. Mereles D, 2006, CIRCULATION, V114, P1482, DOI 10.1161/CIRCULATIONAHA.106.618397
  89. Mitchell Jane A, 2014, Glob Cardiol Sci Pract, V2014, P382, DOI 10.5339/gcsp.2014.53
  90. Muirhead GJ, 2000, BRIT J CLIN PHARMACO, V50, P99, DOI 10.1046/j.1365-2125.2000.00245.x
  91. Nathan SD, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01914-2018
  92. O'Callaghan DS, 2012, EUR RESPIR REV, V21, P218, DOI 10.1183/09059180.00003512
  93. RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203
  94. Olsson KM, 2016, EUR RESPIR REV, V25, P431, DOI 10.1183/16000617.0079-2016
  95. Olsson KM, 2014, CIRCULATION, V129, P57, DOI 10.1161/CIRCULATIONAHA.113.004526
  96. Olsson KM, 2013, SEMIN RESP CRIT CARE, V34, P681, DOI 10.1055/s-0033-1355438
  97. Pergola V, 2015, J CARDIOVASC MED, V16, pS136, DOI 10.2459/JCM.0b013e3283388fb3
  98. PETITPRETZ P, 1994, CIRCULATION, V89, P2722, DOI 10.1161/01.CIR.89.6.2722
  99. Porres-Aguilar M, 2008, ANN HEPATOL, V7, P321, DOI 10.1016/S1665-2681(19)31832-0
  100. Provencher S, 2006, GASTROENTEROLOGY, V130, P120, DOI 10.1053/j.gastro.2005.10.013
  101. Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917
  102. Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486
  103. Raevens S, 2020, HEPATOLOGY, V71, P1870, DOI 10.1002/hep.31166
  104. Ramsay M A, 1997, Liver Transpl Surg, V3, P494, DOI 10.1053/jlts.1997.v3.pm0009346791
  105. Rosenzweig EB, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01916-2018
  106. Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
  107. Ruiz-Irastorza G, 2013, AUTOIMMUN REV, V12, P410, DOI 10.1016/j.autrev.2012.07.010
  108. Saia F, 2019, JACC-CARDIOVASC INTE, V12, P319, DOI 10.1016/j.jcin.2018.08.002
  109. Sanchez O, 2006, CHEST, V130, P182, DOI 10.1378/chest.130.1.182
  110. Sandoval J, 2001, AM J RESP CRIT CARE, V164, P1682, DOI 10.1164/ajrccm.164.9.2106076
  111. Sim JY, 2010, KOREAN J ANESTHESIOL, V58, P4, DOI 10.4097/kjae.2010.58.1.4
  112. Simonneau G, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01913-2018
  113. Boutou AK, 2020, EXPERT OPIN PHARMACO, V21, P1145, DOI 10.1080/14656566.2020.1727446
  114. Sitbon O, 2015, NEW ENGL J MED, V373, P2522, DOI 10.1056/NEJMoa1503184
  115. Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313
  116. Sliwa K, 2016, EUR J HEART FAIL, V18, P1119, DOI 10.1002/ejhf.594
  117. SPEICH R, 1991, CHEST, V100, P1268, DOI 10.1378/chest.100.5.1268
  118. Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC
  119. Terek D, 2013, J RES MED SCI, V18, P73
  120. Thomas E, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006144